Tudor Jianu
Rheumatology · Las Vegas, NVNPI 1821039546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 474 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Amgen at 33.3% of the total. Reporting peaked in 2020 at $3,330 and has fallen 89.6% since, to $346 in 2023.
Across 474 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$600
- Johnson & Johnson$441
- GSK$371
- Lilly USA, LLC$365
- plus $2K from 19 others
What the payments were for
- Food & beverage$7,696100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 139 | $2,565 |
| AbbVie | 91 | $1,655 |
| E.r. Squibb & Sons, L.L.C. | 46 | $600 |
| Johnson & Johnson | 23 | $441 |
| GSK | 25 | $371 |
| Lilly USA, LLC | 40 | $365 |
| Genentech USA, Inc. | 20 | $347 |
| Novartis | 18 | $233 |
| Boehringer Ingelheim | 10 | $188 |
| Pfizer | 15 | $178 |
| Ferring Pharmaceuticals Inc. | 16 | $176 |
| AstraZeneca(2 entities) | 3 | $149 |
| Bristol Myers Squibb | 6 | $93 |
| Orthogenrx Inc. | 4 | $63 |
| Bioventus LLC | 2 | $47 |
| Sanofi | 3 | $47 |
| Janssen Scientific Affairs, LLC | 4 | $37 |
| Viiv Healthcare Company | 1 | $31 |
| Radius Health, Inc. | 2 | $24 |
| Organon | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,709 in reported general payments places this provider in the 75th percentile of 43 rheumatology providers in Nevada.
Other rheumatology in Las Vegas
- Ewa OlechLas Vegas$287K
- Walter ChathamLas Vegas$197K
- George KellyLas Vegas$185K
- Nasim DaoudLas Vegas$109K
- William KimLas Vegas$16K
- Aida LoudyiLas Vegas$10K
- Khalil Ibrahim BourjiLas Vegas$7K
- Neil BraunsteinLas Vegas$6K
- Michael CliffordLas Vegas$4K
- Chen TangLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.